BR9707501A - Composto composição farmacêutica e uso do composto - Google Patents
Composto composição farmacêutica e uso do compostoInfo
- Publication number
- BR9707501A BR9707501A BR9707501A BR9707501A BR9707501A BR 9707501 A BR9707501 A BR 9707501A BR 9707501 A BR9707501 A BR 9707501A BR 9707501 A BR9707501 A BR 9707501A BR 9707501 A BR9707501 A BR 9707501A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- compound pharmaceutical
- composition
- pharmaceutical
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96200334 | 1996-02-13 | ||
| EP96200421 | 1996-02-19 | ||
| EP96202337 | 1996-08-23 | ||
| PCT/EP1997/000625 WO1997030073A1 (en) | 1996-02-13 | 1997-02-11 | Serine protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9707501A true BR9707501A (pt) | 1999-07-27 |
Family
ID=27237508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9707501A BR9707501A (pt) | 1996-02-13 | 1997-02-11 | Composto composição farmacêutica e uso do composto |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6034067A (pt) |
| EP (1) | EP1007544A1 (pt) |
| JP (1) | JP2000505437A (pt) |
| KR (1) | KR19990082424A (pt) |
| CN (1) | CN1212706A (pt) |
| AU (1) | AU719216B2 (pt) |
| BR (1) | BR9707501A (pt) |
| CA (1) | CA2246256A1 (pt) |
| CZ (1) | CZ291690B6 (pt) |
| HU (1) | HUP9901187A3 (pt) |
| NO (1) | NO983688L (pt) |
| NZ (1) | NZ331327A (pt) |
| PL (1) | PL328307A1 (pt) |
| RU (1) | RU2191193C2 (pt) |
| TR (1) | TR199801569T2 (pt) |
| TW (1) | TW487708B (pt) |
| WO (1) | WO1997030073A1 (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9900043D0 (sv) * | 1999-01-11 | 1999-01-11 | Astra Ab | New use |
| TW523513B (en) * | 1996-03-01 | 2003-03-11 | Akzo Nobel Nv | Serine protease inhibitors |
| US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
| US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
| US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| WO1998016523A2 (en) * | 1996-10-11 | 1998-04-23 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
| US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6133256A (en) * | 1997-04-14 | 2000-10-17 | Cor Therapeutics Inc | Selective factor Xa inhibitors |
| EP0977772A1 (en) | 1997-04-14 | 2000-02-09 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| US6369063B1 (en) | 1997-04-14 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| AU747531B2 (en) | 1997-04-14 | 2002-05-16 | Millennium Pharmaceuticals, Inc. | Selective factor Xa inhibitors |
| US6214841B1 (en) | 1997-05-15 | 2001-04-10 | Eli Lilly And Company | Antithrombotic compound |
| US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
| US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| WO2000047207A1 (en) | 1999-02-09 | 2000-08-17 | Bristol-Myers Squibb Company | LACTAM INHIBITORS OF FXa AND METHOD |
| US6344450B1 (en) | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
| ATE253558T1 (de) | 1999-09-13 | 2003-11-15 | Dimensional Pharm Inc | Azazykloalkanone serin-protease-hemmer |
| US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
| AU2001288819A1 (en) | 2000-09-11 | 2002-03-26 | Genentech, Inc. | Amidine inhibitors of serine proteases |
| HUP0304058A2 (hu) | 2001-01-30 | 2004-04-28 | Bristol-Myers Squibb Company | Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
| CN100513398C (zh) | 2002-12-03 | 2009-07-15 | Axys药物公司 | 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物 |
| AU2004249670A1 (en) | 2003-05-20 | 2004-12-29 | Genentech, Inc. | Acylsulfamide inhibitors of factor VIIa |
| JP2007500221A (ja) | 2003-05-20 | 2007-01-11 | ジェネンテック・インコーポレーテッド | 第ＶＩＩａ因子のベンゾフラン阻害剤 |
| US7405210B2 (en) * | 2003-05-21 | 2008-07-29 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| ATE483708T1 (de) | 2004-03-08 | 2010-10-15 | Prosidion Ltd | Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase |
| ATE424821T1 (de) | 2004-12-02 | 2009-03-15 | Prosidion Ltd | Pyrrolopyridin-2-karbonsäureamide |
| EP4178955A1 (en) | 2020-07-11 | 2023-05-17 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5037808A (en) * | 1988-07-20 | 1991-08-06 | Monsanto Co. | Indolyl platelet-aggregation inhibitors |
| CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
| ZW11290A1 (en) * | 1989-07-14 | 1990-10-31 | Smithkline Beecham Corp | Hemoregulatory peptides |
| US5332726A (en) * | 1989-09-29 | 1994-07-26 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Antithrombotic peptides and pseudopeptides |
| EP0699074B1 (en) * | 1993-04-30 | 2002-11-13 | Merck & Co. Inc. | Thrombin inhibitors |
| SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
| ZA951618B (en) * | 1994-03-04 | 1996-08-27 | Lilly Co Eli | Antithrombotic agents |
| ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
| US5561146A (en) * | 1994-06-10 | 1996-10-01 | Bristol-Myers Squibb Company | Modified guanidino and amidino thrombin inhibitors |
| JPH10503176A (ja) * | 1994-06-17 | 1998-03-24 | コーバス インターナショナル， インコーポレイテッド | 酵素インヒビターとしての３−アミノ−２−オキソ−１−ピペリジン酢酸誘導体 |
| DE4421052A1 (de) * | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
| JPH0820597A (ja) * | 1994-07-07 | 1996-01-23 | Meiji Seika Kaisha Ltd | トロンビン阻害作用を有する複素環カルボニル化合物 |
| CN1175259A (zh) * | 1994-12-22 | 1998-03-04 | 生化制药有限公司 | 低分子量双环凝血酶抑制剂 |
| IL120310A (en) * | 1996-03-01 | 2002-02-10 | Akzo Nobel Nv | Serine protease inhibitors and pharmaceuticals containing them |
-
1997
- 1997-02-11 CA CA002246256A patent/CA2246256A1/en not_active Abandoned
- 1997-02-11 PL PL97328307A patent/PL328307A1/xx unknown
- 1997-02-11 US US09/125,169 patent/US6034067A/en not_active Expired - Fee Related
- 1997-02-11 KR KR1019980706157A patent/KR19990082424A/ko not_active Ceased
- 1997-02-11 AU AU16025/97A patent/AU719216B2/en not_active Ceased
- 1997-02-11 RU RU98117075/04A patent/RU2191193C2/ru active
- 1997-02-11 BR BR9707501A patent/BR9707501A/pt unknown
- 1997-02-11 CZ CZ19982565A patent/CZ291690B6/cs not_active IP Right Cessation
- 1997-02-11 WO PCT/EP1997/000625 patent/WO1997030073A1/en not_active Ceased
- 1997-02-11 TR TR1998/01569T patent/TR199801569T2/xx unknown
- 1997-02-11 NZ NZ331327A patent/NZ331327A/xx unknown
- 1997-02-11 EP EP97902361A patent/EP1007544A1/en not_active Withdrawn
- 1997-02-11 HU HU9901187A patent/HUP9901187A3/hu unknown
- 1997-02-11 JP JP9528972A patent/JP2000505437A/ja active Pending
- 1997-02-11 CN CN97192762A patent/CN1212706A/zh active Pending
- 1997-02-21 TW TW086102133A patent/TW487708B/zh active
-
1998
- 1998-08-12 NO NO983688A patent/NO983688L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2191193C2 (ru) | 2002-10-20 |
| NZ331327A (en) | 2000-01-28 |
| AU719216B2 (en) | 2000-05-04 |
| US6034067A (en) | 2000-03-07 |
| KR19990082424A (ko) | 1999-11-25 |
| NO983688L (no) | 1998-10-12 |
| HUP9901187A3 (en) | 1999-11-29 |
| CZ291690B6 (cs) | 2003-05-14 |
| EP1007544A1 (en) | 2000-06-14 |
| CZ256598A3 (cs) | 1999-01-13 |
| HUP9901187A2 (hu) | 1999-08-30 |
| NO983688D0 (no) | 1998-08-12 |
| PL328307A1 (en) | 1999-01-18 |
| JP2000505437A (ja) | 2000-05-09 |
| TR199801569T2 (xx) | 1998-10-21 |
| AU1602597A (en) | 1997-09-02 |
| WO1997030073A1 (en) | 1997-08-21 |
| TW487708B (en) | 2002-05-21 |
| CA2246256A1 (en) | 1997-08-21 |
| CN1212706A (zh) | 1999-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9500784A (pt) | Composto e formulação farmacêutica | |
| BR9504060A (pt) | Composto e formulação farmacêutica | |
| BR9707808A (pt) | Composto composição farmacêutica e uso do composto | |
| BR9706311A (pt) | Compostos de estilbeno composição farmacêutica composição cosmética e uso de uma composição cosmética | |
| BR9708400A (pt) | Composição sua preparação e uso | |
| BR9706968A (pt) | Uso de antagonistas de alfa-ppar e gama-ppar para o tratamento de sindrome x | |
| FI963126L (fi) | Stanoliseos ja sen käyttö | |
| BR9702553A (pt) | Composição cosmética e utilização | |
| BR9707812A (pt) | Composto composto farmacêutica e uso do composto | |
| BR9711191A (pt) | Composto e uso do mesmo | |
| BR9508677A (pt) | Copolímero prodesso de preparação do mesmo e composição orgânica | |
| BR9506583A (pt) | Composição cosmética e uso da mesma | |
| FI972245A0 (fi) | Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät | |
| DE69724629D1 (de) | Zusammensetzungen und deren verwendungen | |
| DE69524592D1 (de) | 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung | |
| BR9708790A (pt) | Composto uso de um composto e formulação farmacêutica | |
| BR9612413A (pt) | Composto uso do mesmo e composição farmacêutica | |
| BR9402143A (pt) | Composto, composição e uso | |
| BR9703378A (pt) | Compostos de estilbeno e seu uso | |
| IT1271271B (it) | Dispositivo per la miscelazione e la preparazione di materiali scorrevoli | |
| BR9509688A (pt) | Composto e composição farmacêutica | |
| BR9507768A (pt) | Composição farmacêutica | |
| ID18698A (id) | Komposisi farmasi | |
| DE69708418D1 (de) | Naphthylverbindungen und Zusammensetzungen | |
| ID16838A (id) | Komposisi dekafluoropentana |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |